Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Jim Van Meerten

Xeris Biopharma - Possibly the best Pharma Stock

Summary

  • Xeris Biopharmaceuticals has shown strong technical buy signals, with a 30.03% gain since the Trend Seeker buy signal on 1/28.

     

  • The company offers innovative therapies like Gvoke, Keveyis, and Recorlev, and is developing XP-8121 and XeriSol/XeriJect technologies.

  • Barchart indicators show 100% technical buy signals, a 95.32% gain in the last year, and a Trend Seeker buy signal.

  • Analysts are bullish with 4 strong buys, 1 buy, and 1 hold, despite MorningStar's view of the stock being 12% overvalued.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.